RecruitingNCT05187312
Registry for Advanced Endoscopy
Research Registry for Endoscopic Treatment and Diagnostics
Sponsor
Region Stockholm
Enrollment
1,000 participants
Start Date
Jan 14, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Clinical indication for endoscopic intervention/procedure
Exclusion Criteria2
- No informed consent
- Age \<18 years
Interventions
PROCEDUREEndoscopic retrograde Cholangio- pancreatography
Endoscopic intervention in the biliary or pancreatic duct
PROCEDUREEndoscopic ultrasound
Endoscopic investigation/intervention with ultrasound
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05187312
Related Trials
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
NCT056635158 locations
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
NCT066480571 location
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT0624477126 locations